News & Updates
The Hamilton Spectator building will soon become a hub for emerging life sciences companies. McMaster Innovation Park is the new owner of The Spectator building at 44 Frid St., the newspaper’s home since 1976. MIP plans to convert the building into a state-of-the-art hub complete with labs and office space for emerging life sciences companies.…
Read More
The 2020 Medicine by Design New Ideas Awards will focus on seeding new ideas that have strong potential to advance regenerative medicine research. Each funded project will receive up to $100,000 per year for a two-year period from July 1, 2020, to June 30, 2022. Proposed projects must align with at least one of the…
Read More
The ONtrepreneurs (Ontario Neurotech Entrepreneurs) Program is Canada’s single largest award that catalyzes early stage entrepreneurs to commercialize brain-related technologies by accessing funding and support to launch or grow their neurotechnology ventures. Application for the 2020 ONtrepreneurs Competition is NOW OPEN! Click the button below to read his entire Article! Continue To The Site To…
Read More
Meet with Christopher Kata, Director of Sales & Marketing March 17th to 18th, in Milwaukee, Wisconsin. Christopher is in town on business and has availability for additional meetings. Arrange to meet in person and learn how TrialStat is leading the way with their innovative, interoperable Electronic Data Capture (Data Management) platform. Learn how you can…
Read More
Meet with Christopher Kata, Director of Sales and Marketing March 3rd to 4th, San Diego, California. Christopher is in town for client meetings and has availability for additional meetings. Christopher Kata, Director of Sales & Marketing905 [email protected] Arrange to meet in person and learn how TrialStat is leading way in innovative, interoperable Electronic Data Capture…
Read More
We met incredible researchers, partners, and solution providers at the event, and thanks to our on the ground team Christopher Kata, Heather Williams, and Chris Hamelin, we were able to engage with them using our recently released eClinical Technology interoperability diagram that maps out TrialStat’s innovative advances in Trial Management Technology, Vendor Neutral Imaging Archive,…
Read More
Bruno Villetelle, Head of Data and Digital, Novartis Global Drug Development, wrote a very succinct summary of the core topics covered at J.P. Morgan 2020. We’re excited to see the continued momentum behind these digital trends and how we’re enabling Sponsors to take advantage of Real World Data, Machine Learning and so much more through…
Read More
This may just be the first drug to be generated using artificial intelligence (AI) which has now entered clinical trials in Japan. “The project has been particularly heralded for the speed it took to complete – taking just 12 months when compared to the typical five years it takes drug companies to complete the research…
Read More
Microsoft has recently announced a $40 Million investment in AI for Health Initiatives. “Through its AI for Good projects, Microsoft is applying lessons from software to artificial intelligence technologies that are under development. In the case of health, Microsoft officials said their mission is to use insights derived from AI technologies and techniques to search…
Read More
“Biomedical data scientists at the Stanford University School of Medicine have shown that the number of genes a cell uses to make RNA is a reliable indicator of how developed the cell is, a finding that could make it easier to target cancer-causing genes.” Click the button below to read the entire Article! Continue Reading…
Read MoreRequest Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?